Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment
Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment
复制标题
线粒体复合物 I 抑制剂通过同时酸化细胞内和细胞外环境来抑制肿瘤生长
DOI:
10.1016/j.isci.2021.103497
复制
发表时间:
2021
期刊:
影响因子:
5.8
通讯作者:
M. Shi
中科院分区:
文献类型:
--
作者:
J. Yoshida;T. Ohishi;H. Abe;S. Ohba;H. Inoue;I. Usami;M. Amemiya;R. Oriez;C. Sakashita;S. Dan;M. Sugawara;T. Kawaguchi;J. Ueno;Y. Asano;A. Ikeda;M. Takamatsu;G. Amori;Y. Kondoh;K. Honda;H. Osada;T. Noda;T. Watanabe;T. Shimizu;M. Shi
The disruption of the tumor microenvironment (TME) is a promising anti-cancer strategy, but its effective targeting for solid tumors remains unknown. Here, we investigated the anti-cancer activity of the mitochondrial complex I inhibitor intervenolin (ITV), which modulates the TME independent of energy depletion. By modulating lactate metabolism, ITV induced the concomitant acidification of the intra- and extracellular environment, which synergistically suppressed S6K1 activity in cancer cells through protein phosphatase-2A-mediated dephosphorylation via G-protein-coupled receptor(s). Other complex I inhibitors including metformin and rotenone were also found to exert the same effect through an energy depletion-independent manner as ITV. In mouse and patient-derived xenograft models, ITV was found to suppress tumor growth and its mode of action was further confirmed. The TME is usually acidic owing to glycolytic cancer cell metabolism, and this condition is more susceptible to complex I inhibitors. Thus, we have demonstrated a potential treatment strategy for solid tumors.